Exagen Inc. (XGN) DCF Valuation

Exagen Inc. (XGN) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Exagen Inc. (XGN) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Discover Exagen Inc.'s (XGN) true potential with our professional-grade DCF Calculator! Adjust key assumptions, explore various scenarios, and assess how changes influence Exagen Inc.'s (XGN) valuation – all within a single Excel template.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 40.4 42.0 48.3 45.6 52.5 56.3 60.3 64.7 69.3 74.3
Revenue Growth, % 0 3.93 15.07 -5.66 15.33 7.17 7.17 7.17 7.17 7.17
EBITDA -7.9 -13.7 -23.1 -43.1 -19.2 -26.0 -27.9 -29.9 -32.0 -34.3
EBITDA, % -19.64 -32.53 -47.83 -94.62 -36.45 -46.21 -46.21 -46.21 -46.21 -46.21
Depreciation .6 .5 .9 2.1 2.2 1.5 1.6 1.7 1.9 2.0
Depreciation, % 1.46 1.3 1.96 4.63 4.13 2.7 2.7 2.7 2.7 2.7
EBIT -8.5 -14.2 -24.1 -45.2 -21.3 -27.5 -29.5 -31.6 -33.9 -36.3
EBIT, % -21.1 -33.83 -49.8 -99.25 -40.57 -48.91 -48.91 -48.91 -48.91 -48.91
Total Cash 72.1 57.4 99.4 62.4 36.5 52.9 56.7 60.7 65.1 69.7
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 5.7 8.9 9.7 6.1 6.6
Account Receivables, % 14.15 21.23 19.99 13.34 12.47
Inventories 1.4 1.2 1.1 1.8 2.9 2.0 2.2 2.3 2.5 2.7
Inventories, % 3.53 2.87 2.26 3.94 5.46 3.61 3.61 3.61 3.61 3.61
Accounts Payable 1.5 3.0 2.5 3.0 3.1 3.2 3.5 3.7 4.0 4.3
Accounts Payable, % 3.65 7.18 5.16 6.69 5.96 5.73 5.73 5.73 5.73 5.73
Capital Expenditure -.4 -.5 -2.4 -4.3 -.8 -2.0 -2.2 -2.3 -2.5 -2.7
Capital Expenditure, % -0.99785 -1.08 -4.91 -9.48 -1.58 -3.61 -3.61 -3.61 -3.61 -3.61
Tax Rate, % -0.1395 -0.1395 -0.1395 -0.1395 -0.1395 -0.1395 -0.1395 -0.1395 -0.1395 -0.1395
EBITAT -8.5 -14.1 -24.2 -45.0 -21.4 -27.5 -29.5 -31.6 -33.8 -36.3
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF -14.0 -15.5 -26.8 -43.7 -21.5 -29.7 -30.6 -32.8 -35.1 -37.6
WACC, % 10.59 10.58 10.59 10.58 10.59 10.59 10.59 10.59 10.59 10.59
PV UFCF
SUM PV UFCF -122.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) -38
Terminal Value -447
Present Terminal Value -270
Enterprise Value -393
Net Debt -13
Equity Value -380
Diluted Shares Outstanding, MM 18
Equity Value Per Share -21.48

What You Will Receive

  • Comprehensive Financial Model: Exagen Inc.'s (XGN) actual data facilitates accurate DCF valuation.
  • Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential parameters.
  • Real-Time Calculations: Instant updates allow you to view results immediately as you adjust inputs.
  • Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
  • Flexible and Reusable: Designed for adaptability, enabling repeated application for in-depth forecasts.

Key Features

  • Comprehensive Historical Data: Exagen Inc.’s historical financial statements and pre-filled projections.
  • Customizable Parameters: Adjust WACC, tax rates, revenue growth, and EBITDA margins as needed.
  • Real-Time Valuation: Instantly view Exagen Inc.’s intrinsic value recalculating on the fly.
  • Intuitive Visualizations: Interactive dashboard charts present valuation outcomes and essential metrics.
  • Designed for Precision: A reliable tool tailored for analysts, investors, and finance professionals.

How It Works

  • 1. Access the Template: Download and open the Excel file containing Exagen Inc.’s (XGN) preloaded data.
  • 2. Modify Assumptions: Adjust key inputs such as growth rates, WACC, and capital expenditures.
  • 3. See Results Instantly: The DCF model automatically computes intrinsic value and NPV.
  • 4. Explore Scenarios: Evaluate various forecasts to assess different valuation possibilities.
  • 5. Present with Assurance: Deliver professional valuation insights to enhance your decision-making.

Why Choose Exagen Inc. (XGN) Calculator?

  • Precision: Utilizes Exagen's real financial data for reliable calculations.
  • Adaptability: Crafted to allow users to easily adjust and test various inputs.
  • Efficiency: Eliminate the need to create a financial model from the ground up.
  • Expert-Level: Built with the accuracy and functionality expected by financial professionals.
  • Intuitive: Simple to navigate, suitable for users with varying levels of financial expertise.

Who Should Use This Product?

  • Investors: Evaluate Exagen Inc.’s (XGN) market position before making investment decisions.
  • CFOs and Financial Analysts: Optimize valuation methodologies and assess financial forecasts.
  • Startup Founders: Understand the valuation strategies of established companies like Exagen Inc. (XGN).
  • Consultants: Create detailed valuation analyses and reports for client engagements.
  • Students and Educators: Utilize current data from Exagen Inc. (XGN) to learn and teach valuation principles.

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Exagen Inc. (XGN) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), encompassing parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models illustrating intrinsic value with comprehensive calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to aid in analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Exagen Inc. (XGN).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to facilitate result analysis.

No products were found matching.